Sector overview
Drugmakers, hospitals and diagnostics companies serving both Indian and export markets. Compare pipelines of profitability, returns and valuations.
| Company | Market cap | P/E | ROE | Rev CAGR (3y) |
|---|---|---|---|---|
| 3B Blackbio Dx Limited3BBLACKBIO | ₹1,185 Cr | 20.2 | 18.5% | 31.8% |
| Jeena Sikho Lifecare LimitedJSLL | ₹4,282 Cr | 19.3 | 47.5% | 57.5% |
| Anthem Biosciences LimitedANTHEM | ₹47,142 Cr | 79.4 | 19.5% | 26.2% |
| Syncom Formulations (India) LimitedSYNCOMF | ₹1,943 Cr | 25.4 | 18.3% | 30.1% |
| One Global Service Provider LimitedONEGLOBAL | ₹874 Cr | 12.5 | 57.4% | 202.4% |
| Amwill Health Care LimitedAMWILL | ₹83 Cr | 7.5 | 13.6% | 17.1% |
| Alembic LimitedALEMBICLTD | ₹2,238 Cr | 7.1 | 13.0% | 23.6% |
| Thyrocare Technologies LimitedTHYROCARE | ₹7,844 Cr | 48.2 | 27.9% | 16.3% |
| Caplin Point Laboratories LimitedCAPLIPOINT | ₹17,882 Cr | 27.9 | 18.1% | 14.2% |
| Cupid LimitedCUPID | ₹42,537 Cr | 395.8 | 24.0% | 31.1% |
| Natco Pharma LimitedNATCOPHARM | ₹14,237 Cr | 10.0 | 15.4% | 14.6% |
| Lupin LimitedLUPIN | ₹89,252 Cr | 16.7 | 23.9% | 18.9% |
| Prevest Denpro LimitedPREVEST | ₹445 Cr | 22.2 | 16.0% | 12.9% |
| Procter & Gamble Health LimitedPGHL | ₹9,111 Cr | 27.9 | 62.3% | 4.6% |
| Brooks Laboratories LimitedBROOKS | ₹176 Cr | 7.2 | 20.5% | 10.9% |
Companies with an Intrynsic fair-value page are linked. Deeper sector analytics - peer comparison, outlook, results calendar - load below.
Disclaimer: Intrynsic provides educational and informational analysis only. Fair-value figures are estimates based on stated assumptions- they are not investment advice, research recommendations, or an offer to transact in any security. The models rely on assumptions (discount rates, growth, multiples) that may prove wrong and on past financials, which do not guarantee future results; prices also move on macro factors the models don't capture. Intrynsic is not a SEBI-registered investment adviser or research analyst. Markets carry risk; please do your own research or consult a registered adviser before making investment decisions. Prices shown may be delayed end-of-day values. Terms · Privacy